Program overview
Context
Indication: Advanced Melanoma
Mechanism: Unknown
Modality: Unknown
Sponsor: Nanjing Leads Biolabs Co.,
Low Signal
LBL-024 for Injection
LBL-024 for Injection is flagged as low signal because public records show limited public risk signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 0/5
Timeline: 0/5
Recruitment burden: 1/5
Results availability: 0/5
Program risk: 0/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT07099430 | https://clinicaltrials.gov/study/NCT07111546
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT07099430 | Low Signal (RECRUITING) | None | Low Signal | large_enrollment_target_signal |
| NCT07111546 | Low Signal (RECRUITING) | None | Low Signal | rare_population_signal |